Wyeth Calls Off Plan To Acquire Crucell
This article was originally published in The Pink Sheet Daily
Executive Summary
Question remains whether Pfizer or another pharma will make play for Dutch vaccine-focused firm.
You may also be interested in...
Deals Of The Week: J&J/Crucell, Merck/Beijing Genomics Institute …
Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at http://invivoblog.blogspot.com.
Deals Of The Week: J&J/Crucell, Merck/Beijing Genomics Institute …
Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at http://invivoblog.blogspot.com.
Johnson & Johnson Plans Move Into Vaccines With Bid For Remainder Of Crucell
Deal could position the pharma giant to eventually become a sixth major player in the worldwide vaccine space.